Literature DB >> 25187225

Provider knowledge, attitudes, and practices regarding Lyme disease in Arkansas.

Dana Hill1, Talmage Holmes.   

Abstract

Lyme disease (LD), a vector-borne disease, causes illness for many individuals in the United States. All of the conditions for the promulgation of LD are present in one Southern state in the United States; yet this state reports lower numbers of LD than adjacent states. The purpose of this study was to determine associations between this Southern state's primary care providers' knowledge and attitudes regarding the diagnosis and reporting of LD. A quantitative, cross-sectional study was conducted via a mailed questionnaire by the Arkansas Department of Health to 2,693 primary care providers. Respondents were 660 primary care providers from all regions of this state. Secondary data were analyzed using descriptive, Chi square, and logistic regression techniques. Analysis results included the following: a correct response rate of 59.1 % for symptom recognition, of 46.2 % for knowledge of recommended testing processes, and of 78.9 % for knowing LD is a reportable disease. These results compared to the expected norm were significant in every area with p values of .000. Specialty, region, and years of practice were found to be confounding influences in a number of assessment areas.

Entities:  

Mesh:

Year:  2015        PMID: 25187225     DOI: 10.1007/s10900-014-9940-9

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  18 in total

1.  Effects of climate on variability in Lyme disease incidence in the northeastern United States.

Authors:  Susan Subak
Journal:  Am J Epidemiol       Date:  2003-03-15       Impact factor: 4.897

2.  Tick-related illnesses in Arkansas: myths and management.

Authors:  J Gary Wheeler; Jose R Romero
Journal:  J Ark Med Soc       Date:  2012-05

Review 3.  A critical appraisal of "chronic Lyme disease".

Authors:  Henry M Feder; Barbara J B Johnson; Susan O'Connell; Eugene D Shapiro; Allen C Steere; Gary P Wormser; W A Agger; H Artsob; P Auwaerter; J S Dumler; J S Bakken; L K Bockenstedt; J Green; R J Dattwyler; J Munoz; R B Nadelman; I Schwartz; T Draper; E McSweegan; J J Halperin; M S Klempner; P J Krause; P Mead; M Morshed; R Porwancher; J D Radolf; R P Smith; S Sood; A Weinstein; S J Wong; L Zemel
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

Review 4.  A clinical review of Lyme disease in Arkansas.

Authors:  Naveen Patil; J Ryan Bariola; Michael Saccente; Keyur S Vyas; Robert W Bradsher
Journal:  J Ark Med Soc       Date:  2010-02

5.  Lyme disease: knowledge, beliefs, and practices of physicians in a low-endemic area.

Authors:  Bonnie Henry; Alexis Crabtree; David Roth; Doug Blackman; Muhammad Morshed
Journal:  Can Fam Physician       Date:  2012-05       Impact factor: 3.275

Review 6.  Lyme disease: Part II. Management and prevention.

Authors:  Chinmoy Bhate; Robert A Schwartz
Journal:  J Am Acad Dermatol       Date:  2011-04       Impact factor: 11.527

Review 7.  Lyme borreliosis.

Authors:  Gerold Stanek; Gary P Wormser; Jeremy Gray; Franc Strle
Journal:  Lancet       Date:  2011-09-06       Impact factor: 79.321

Review 8.  Reinfection in patients with Lyme disease.

Authors:  Robert B Nadelman; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2007-09-11       Impact factor: 9.079

9.  Lyme disease knowledge, beliefs, and practices of New Hampshire primary care physicians.

Authors:  Julie M Magri; Melissa T Johnson; Timothy A Herring; Jesse F Greenblatt
Journal:  J Am Board Fam Pract       Date:  2002 Jul-Aug

10.  Effect of Climate Change on Lyme Disease Risk in North America.

Authors:  John S Brownstein; Theodore R Holford; Durland Fish
Journal:  Ecohealth       Date:  2005-03       Impact factor: 3.184

View more
  1 in total

1.  Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014.

Authors:  Karen O Johnson; Mark P Nelder; Curtis Russell; Ye Li; Tina Badiani; Beate Sander; Douglas Sider; Samir N Patel
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.